TGA Approval

REVOLADE eltrombopag 25mg film-coated tablet blister pack (158419)

ARTG ID

158419

ARTG Name

REVOLADE eltrombopag 25mg film-coated tablet blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

July 16, 2010

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-CMI-01378-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-01377-3

Ingredient Name

eltrombopag olamine

Empowering clinical research with data-driven insights and AI-powered tools.

REVOLADE eltrombopag 25mg film-coated tablet blister pack (158419) - TGA 批准文号 | MedPath